Abstract
Advances in information concerning brain function in animals and advances in analytical neurochemical methods for determining extremely low levels of compounds in physiological fluids have opened great opportunities for clinical neurochemical studies of autism. Nevertheless, the behavioral deficits in autistic individuals are major obstacles to clarification of the relations between symptoms and biochemical dysfunction in the brain. The fundamental preclinical and clinical studies of serotonin, dopamine, and norepinephrine metabolism related to infantile autism are reviewed, and new studies are suggested, as examples of the productive strategies that will illuminate features of the autistic syndrome in the next decade.
Similar content being viewed by others
Reference notes
Young, J. G. Belendiuk, K., Freedman, D. X., Sternstein, G., & Cohen, D.J. Hyperserotonemia in infantile autism. I. Clinical studies. Submitted for publication, 1982.
Young, J. G., Belendiuk, K., Freedman, D. X., Sternstein, G., & Cohen, D.J. Hyperserotonemia in infantile autism. III. Biochemical correlates of platelet concentrations of serotonin. Submitted for publication, 1982.
References
Amaral, D. G., & Sinnamon, H. M. The locus coeruleus: Neurobiology of a central noradrenergic nucleus.Progress in Neurobiology, 1977,9, 147–196.
Banki, C. M., Molnar, G., & Vojnik, M. Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression.Journal of Affective Disorders, 1981,3, 91–99.
Belmaker, R. H., Hattab, J., & Ebstein, R. P. Plasma dopamine-beta-hydroxylase in childhood psychosis.Journal of Autism and Childhood Schizophrenia, 1978,8, 293–298.
Boullin, D. J. (Ed.).Serotonin in mental abnormalities. New York: Wiley, 1978.
Boullin, D. J., Bhagavan, H. N., O'Brien, R. A., & Youdim, M. B. H. Platelet monoamine oxidase in children with infantile autism. In M. Coleman (Ed.),The autistic syndromes. Amsterdam: North Holland, 1976.
Boullin, D. J., Coleman, M., & O'Brien, R. A. Abnormalities in platelet 5-hydroxytryptamine efflux in patients with infantile autism.Nature, 1970,226, 371–372.
Boullin, D. J., Coleman, M., O'Brien, R., & Rimland, B. Laboratory predictions of infantile autism based on 5-hydroxytryptamine efflux from blood platelets and their correlations with the Rimland E-2 score.Journal of Autism and Childhood Schizophrenia, 1971,1, 63–71.
Brown, G. L., Goodwin, F. K., Ballenger, J. C., Goyer, P. F., & Major, L. F. Aggression in humans correlates with cerebrospinal fluid amine metabolites.Psychiatry Research, 1979,1, 131–139.
Calne, D., Chase, T. N., & Barbeau, A. (Eds.).Advances in neurology (Vol. 9).Dopaminergic mechanisms. New York: Raven Press, 1975.
Campbell, M. Treatment of childhood and adolescent schizophrenia. In J. M. Wiener (Ed.),Psychopharmacology in childhood and adolescence. New York: Basic Books, 1977. Pp. 101–118.
Campbell, M., & Fish, B. Triiodothyronine in schizophrenic children. In A. J. Prange, Jr. (Ed.),The thyroid axis, drugs, and behavior. New York: Raven Press, 1974. Pp. 87–102.
Campbell, M., Friedman, E., DeVito, E., Greenspan, L., & Collins, P. J. Blood serotonin in psychotic and brain-damaged children.Journal of Autism and Childhood Schizophrenia, 1974,4, 33–41.
Campbell, M., Friedman, E., Green, W. H., Collins, P. J., Small, A. M., & Breuer, H. Blood serotonin in schizophrenic children.International Journal of Pharmacopsychiatry, 1975,10, 213–221.
Campbell, M., Friedman, E., Green W. H., Small, A. M., & Burdock, E. I. Blood platelet monoamine oxidase activity in schizophrenic children and their families.Neuropsychobiology, 1976,2, 239–246.
Campbell, M., Small, A. M., Hollander, C. S., Korein, J., Cohen, I. J., Kalmijn, M., & Ferris, S. A controlled crossover study of triiodothyronine in autistic children.Journal of Autism and Childhood Schizophrenia, 1978,8, 371–381.
Cohen, D. J., Caparulo, B. K., Shaywitz, B. A., & Bowers, M. B., Jr. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children: CSF homovanillic acid and 5-hydroxyindoleacetic acid.Archives of General Psychiatry, 1977,34, 545–550.
Cohen, D. J., & Johnson, W. T. Cardiovascular correlates of attention in normal and psychiatrically disturbed children.Archives of General Psychiatry, 1977,34, 561–567.
Cohen, D. J., Shaywitz, B. A., Caparulo, B., Young, J. G., & Bowers, M. B., Jr. Chronic, multiple tics of Gilles de la Tourette's disease: CSF acid monoamine metabolites after probenecid administration.Archives of General Psychiatry, 1978,35, 245–250.
Cohen, D. J., Shaywitz, B. A., Johnson, W. T., & Bowers, M. B., Jr. Biogenic amines in autistic and atypical children: Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.Archives of General Psychiatry, 1974,31, 845–853.
Cohen, D. J., Young, J. G., Lowe, T. L., & Harcherik, D. Thyroid hormone in autistic children.Journal of Autism and Developmental Disorders, 1980,10, 445–450.
Cohen, D. J., Young, J. G., Nathanson, J. A., & Shaywitz, B. A. Clonidine in Tourette's syndrome.Lancet, 1979,2, 551–553.
Cohen, D. J., Young, J. G., & Roth, J. A. Platelet monoamine oxidase in early childhood autism.Archives of General Psychiatry, 1977,34, 534–537.
Coleman, M., Campbell, M., Freedman, L. S., Roffman, M., Ebstein, R. P., & Goldstein, M. Serum dopamine-β-hydroxylase levels in Down's syndrome.Clinical Genetics, 1974,5, 312–315.
Costa, E., & Gessa, G. L.Advances in biochemical psychopharmacology (Vol. 16).Nonstriatal dopaminergic neurons. New York: Raven Press, 1977.
Costall, B., & Naylor, R. J. Extrapyramidal and mesolimbic involvement with the stereotypic activity of d- and 1-amphetamine.European Journal of Pharmacology, 1974,25, 121–129.
Creese, I., & Iversen, S. D. The pharmacological and anatomical substrates of the amphetamine response in the rat.Psychopharmacologia, 1975,39, 345–357.
Crow, T. J. The relationship between lesion site, dopamine neurons and turning behavior in the rat.Experimental Neurology, 1971,32, 247–255.
Donaldson, I., Dolphin, A., Jenner, P., Marsden, C. D., & Pycock, C. The roles of noradrenaline and dopamine in contraversive circling behavior seen after unilateral electrolytic lesions of the locus coeruleus.European Journal of Pharmacology, 1976,39, 179–191.
Fish, B., & Ritvo, E. R. Psychoses of childhood. In J. D. Noshpitz (Ed.),Basic Handbook of child psychiatry (Vol. 2).Disturbances in development. New York: Basic Books, 1979. Pp. 249–304.
Fuxe, K., & Ungerstedt, U. Histochemical biochemical, and functional studies on central monoamine neurons after acute and chronic amphetamine administration. In E. Costa & S. Garattini (Eds.),Amphetamines and related compounds. New York: Raven Press, 1970. Pp. 257–288.
Glick, S. D. Enhancement of spatial preferences by (+)-amphetamine.Neuropharmacology, 1973,12, 43–47.
Glick, S. D., & Jerussi, T. P. Spatial and paw preferences in rats: Their relationship to rate-dependent effects of d-amphetamine.Journal of Pharmacology and Experimental Therapeutics, 1974,188, 714–725.
Goldstein, M. DBH and endogenous total 5-hydroxyindole levels in autistic patients and controls. In M. Coleman (Ed.),The autistic syndrome. Amsterdam: North Holland, 1976. Pp. 57–58.
Hanley, H. G., Stahl, S. M., & Freeman, D. X. Hyperserotonemia and amine metabolites in autistic and retarded children.Archives of General Psychiatry, 1977,34, 521–531.
Hollister, A. S., Breese, G. R., & Cooper, B. R. Comparison of tyrosine hydroxylase and dopamine-β-hydroxylase inhibition with the effects of various 6-hydroxydopamine treatments on d-amphetamine-induced motor activity.Psychopharmacologia, 1974,36, 1–16.
Iversen, S. D. Brain dopamine systems and behavior. In L. L. Iversen, S. D. Iversen, & S. H. Snyder (Eds.),Handbook of psychopharmacology (Vol. 8). New York: Plenum Press, 1977. Pp. 333–384.
Karpatkin, S. Heterogeneity of human platelets. VI. Correlation of platelet function with platelet volume.Blood, 1978,51, 307–316.
Kelly, P. H. Drug-induced motor behavior. In L. L. Iversen, S. D. Iversen, & S. H. Snyder (Eds.),Handbook of psychopharmacology (Vol. 8). New York: Plenum Press, 1977. Pp. 295–331.
Kelly, P. H., & Moore, K. E. Mesolimbic dopamine neurons in the rotational model of nigrostriatal function.Nature, 1976,263, 695–696.
Klawans, H. L., Goetz, C. G., & Perlik, S. Tardive dyskinesia: Review and update.American Journal of Psychiatry, 1980,137, 900–908.
Lake, C. R. Ziegler, M. G., & Murphy, D. L. Increased norepinephrine levels and decreased DBH in primary autism.Archives of General Psychiatry, 1977,35, 553–556.
Leckman, J. F., Cohen, D. J., Shaywitz, B. A., Caparulo, B. K., Heninger, G. R., & Bowers, M. B., Jr. CSF monoamine metabolites in child and adult psychiatric patients.Archives of General Psychiatry, 1980,37, 677–681.
Lucas, A. R., Warner, K., & Gottlieb, J. Serotonin uptake by platelets.Biological Psychiatry, 1971,3, 123–128.
Lyon, M., & Robbins, T. The action of central nervous system stimulant drugs: A general theory concerning amphetamine effects. InCurrent developments in psychopharmacology (Vol. 2). New York: Halsted Press, 1975. Pp. 80–163.
McKenzie, G. M. Role of the tuberculum olfactorium in stereotyped behavior induced by apomorphine in the rat.Psychopharmacologia, 1972,23, 212–219.
Moore, R. Y., & Bloom, F. E. Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems. In W. M. Cowan, Z. W. Hall, & E. R. Kandel (Eds.),Annual Review of neuroscience (Vol. 2). Palo Alto: Annual Reviews, 1979. Pp. 113–168.
Murphy, D. L., Costa, J. L., Shafer, B., & Corash, L. Monoamine oxidase activity in different density gradient fractions of human platelets.Psychopharmacology, 1978,59, 193–197.
Noth, R. H., & Mulrow, P. J. Serum dopamine-β-hydroxylase as an index of sympathetic nervous system activity in man.Circulation Research, 1976,38, 2–5.
Pare, C. M. B., Sandler, M., & Stacey, R. S. The relationship between decreased 5-hydroxyindole metabolism and mental defects in phenylketonuria.Archives of Diseases of Childhood, 1959,34, 422–425.
Pare, C. M. B., Sandler, M., & Stacey, R. S. 5-hydroxyindoles in mental deficiency.Journal of Neurology, Neurosurgery, and Psychiatry, 1960,23, 341–346.
Partington, M. W., Tu, J. B., & Wong, C. Y. Blood serotonin levels in severe mental retardation.Developmental Medicine and Child Neurology, 1973,15, 616–627.
Pijnenburg, A. J. J., Honig, W. M. M., van der Heyden, J. A. M., & van Rossum, J. M. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity.European Journal of Pharmacology, 1976,35, 45–58.
Randrup, A., & Munkvad, I. Biochemical, anatomical, and psychological investigations of stereotyped behavior induced by amphetamine. In E. Costa & S. Garattini (Eds.),Amphetamines and related compounds. New York: Raven Press, 1970. Pp. 695–713.
Redmond, D. E., Jr., & Huang, Y. H. New evidence for a locus coeruleus-norepinephrine connection with anxiety.Life Sciences, 1979,25, 2149–2162.
Ritvo, E. R., & Freeman, B. J. National Society for Autistic Children definition of the syndrome of autism.Journal of the American Academy of Child Psychiatry, 1978,17, 565–576.
Ritvo, E. R., Yuwiler, A., Geller, E., Ornitz, E. M., Saeger, K., & Plotkin, S. Increased blood serotonin and platelets in early infantile autism.Archives of General Psychiatry, 1970,23, 566–572.
Roberts, P. J., Woodruff, G. N., & Iversen, L. L.Advances in biochemical psychopharmacology (Vol. 19).Dopamine. New York: Raven Press, 1978.
Roth, J. A., Young, J. G., & Cohen, D. J. Platelet monoamine oxidase activity in children and adolescents.Life Sciences, 1976,18, 919–924.
Sankar, D. V. S. Biogenic amine uptake by blood platelets and RBC in childhood schizophrenia.Acta Paedopsychiatrica (Basel), 1970,37, 174–183.
Sankar, D. V. S., Gold, E., Phipps, E., & Sankar, D. B. General metabolic studies on schizophrenic children.Annals of the New York Academy of Sciences, 1962,96, 392–397.
Schain, R. J., & Freedman, D. X. Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded children.Journal of Pediatrics, 1961,58, 315–320.
Schanberg, S. M., & Kirshner, N. Serum dopamine-β-hydroxylase as an indicator of sympathetic activity and primary hypertension.Biochemical Pharmacology, 1976,25, 617–621.
Shaywitz, B. A., Cohen, D. J., Leckman, J. F., Young, J. G., & Bowers, M. B., Jr. Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.Developmental Medicine and Child Neurology, 1980,22, 748–754.
Society for Neuroscience.Receptor binding techniques. Bethesda: Society for Neuroscience, 1980.
Takahashi, S., Kanai, H., & Miyamoto, Y. Reassessment of elevated serotonin levels in blood platelets in early infantile autism.Journal of Autism and Childhood Schizophrenia, 1976, 6, 317–326.
Träskman, L., Åsberg, M., Bertilsson, L., & Sjöstrand, L. Monoamine metabolites in CSF and suicidal behavior.Archives of General Psychiatry, 1981,38, 631–636.
Tu, J., & Zellwenger, H. Blood serotonin deficiency in Down's syndrome.Lancet, 1965,1, 730.
Ungerstedt, U. Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behavior.Acta Physiologica Scandinavíca, 1971,83(Suppl. 367), 49–68.
Ungerstedt, U., & Arbuthnott, G. W. Quantitative recording of rotational behavior in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system.Brain Research, 1970,24, 485–493.
Ungerstedt, U., Ljungberg, T., & Schultz, W. Dopamine receptor mechanism: Behavioral and electrophysiological studies. In P. J. Roberts, G. N. Woodruff, & L. L. Iversen (Eds.),Advances in biochemical psychopharmacology (Vol. 19).Dopamine. New York: Raven Press, 1978. Pp. 311–321.
Waddington, J. L., & Crow, T. L. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: Co-operative interactions of serotonin and dopamine in neostriatum.Life Sciences, 1979,25, 1307–1314.
Weinshilboum, R., & Axelrod, J. Serum dopamine-β-hydroxylase after chemical sympathectomy.Science, 1971,173, 931–934.
Williams, L. T., & Lefkowitz, R.J. Receptor binding studies in adrenergic pharmacology. New York: Raven Press, 1978.
Wise, C. D., & Stein, L. Dopamine-beta-hydroxylase deficits in the brain of schizophrenic patients.Science, 1973,181, 344–347.
Woodruff, G. N. Biochemical and pharmacological studies on dopamine receptors. In P. J. Roberts, G. N. Woodruff, & L. L. Iversen (Eds.),Advances in biochemical psychopharmacology (Vol. 19).Dopamine. New York: Raven Press, 1978. Pp. 89–118.
Young, J. G., Cohen, D. J., Brown, S.-L., & Caparulo, B. K. Decreased urinary free catecholamines in childhood autism.Journal of the American Academy of Child Psychiatry, 1978,17, 671–678.
Young, J. G., Cohen, D. J., Caparulo, B. K., Brown, S.-L., & Maas, J. W. Decreased 24-hour urinary MHPG in childhood autism.American Journal of Psychiatry, 1979,136, 1055–1057.
Young, J. G., Cohen, D. J., Hattox, S. E., Kavanagh, M. E., Anderson, G. M., Shaywitz, B. A., & Maas, J. W. Plasma free MHPG and neuroendocrine responses to challenge doses of clonidine in Tourette's syndrome: Preliminary report.Life Sciences, 1981,29, 1467–1475.
Young, J. G., Cohen, D. J., Kavanagh, M. E., Landis, H. D., Shaywitz, B. A., & Maas, J. W. Cerebrospinal fluid, plasma, and urinary MHPG in children.Life Sciences, 1981,28, 2837–2845.
Young, J. G., Cohen, D. J., Shaywitz, B. A., Anderson, ¯G. M., & Maas, J. W. Clinical studies of MHPG in childhood and adolescence. In J. Maas (Ed.),MHPG in psychopathology, New York: Academic Press, 1982.
Young, J. G., Kyprie, R. M., Ross, N. T., & Cohen, D. J. Serum dopamine-betahydroxylase activity: Clinical applications in child psychiatry.Journal of Autism and Developmental Disorders, 1980,10, 1–14.
Yuwiller, A., Ritvo, E. R., Geller, E., Glousman, R., Schneiderman, G., & Matsuno, D. Uptake and efflux of serotonin from platelets of autistic and nonautistic children.Journal of Autism and Childhood Schizophrenia, 1975,5, 83–98.
Author information
Authors and Affiliations
Additional information
The research was supported in part by MHCRC grant MH30929, CCRC grant RR00125, NICHD grant HD03008, the William T. Grant Foundation, Mr. Leonard Berger, The Solomon R. & Rebecca D. Baker Foundation, Inc., and the MacArthur Foundation. We are grateful to the children and families who have collaborated with us in this research, and to Dr. Amy Lettick, Mr. Daniel Davis, and the staff of Benhaven in New Haven, Connecticut, for their guidance and help in these investigations. We appreciate the excellent research assistance of Ms. Barbara Caparulo, Ms. Ellen Waldron, and Ms. Diane Harcherik, and the careful preparation of the manuscript by Ms. Margrethe Cone. The children were evaluated in the Children's Research Center, under the direction of Myron Genel, M.D., and Mary Carey, R.N.
Rights and permissions
About this article
Cite this article
Young, J.G., Kavanagh, M.E., Anderson, G.M. et al. Clinical neurochemistry of autism and associated disorders. J Autism Dev Disord 12, 147–165 (1982). https://doi.org/10.1007/BF01531305
Issue Date:
DOI: https://doi.org/10.1007/BF01531305